Insider trading

Period: 120 months Stock: TNYA Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

42 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

42 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

42 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

42 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
42 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
42 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

42 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Aug 2026
Ali Faraz Chief Executive Officer
Sold at will 4×
$15.78K 22,232 at 0.71
5.1%
Not planned
17 Aug 2026
Tingley Whittemore Chief Medical Officer
Sold at will 4×
$5.27K 7,424 at 0.71
3.4%
Not planned
18 May 2026
Ali Faraz Chief Executive Officer
Sold at will
$2.69K 3,390 at 0.79
0.8%
Not planned
18 May 2026
Tingley Whittemore Chief Medical Officer
Sold at will
$2.48K 3,121 at 0.79
1.4%
Not planned
18 May 2026
Higa Tomohiro SVP, Finance
Sold at will
$1.18K 1,485 at 0.79
1.2%
Not planned
25 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$1.98M 3,511,826 at 0.56
100%
Sold half or more
24 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$405.14K 658,440 at 0.62
28.5%
Not planned
23 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$182.74K 306,000 at 0.60
13.5%
Not planned
20 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$322.04K 523,734 at 0.61
19.9%
Not planned
17 Feb 2026
Ali Faraz Chief Executive Officer
Sold at will 3×
$9.56K 14,862 at 0.64
3.2%
Not planned
17 Feb 2026
Tingley Whittemore Chief Medical Officer
Sold at will 3×
$3.32K 5,160 at 0.64
2.3%
Not planned
17 Feb 2026
Higa Tomohiro SVP, Finance
Sold at will 3×
$2.23K 3,469 at 0.64
2.8%
Not planned
11 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$2.76M 4,056,573 at 0.68
63.3%
Sold half or more
10 Feb 2026
COLUMN GROUP III GP, LP 10% owner · indirect
Sold at will 2×
$280.51K 343,717 at 0.82
7.5%
Not planned
17 Nov 2025
Ali Faraz Chief Executive Officer
Sold at will
$4.16K 3,126 at 1.33
1.0%
Not planned
17 Nov 2025
Tingley Whittemore Chief Medical Officer
Sold at will
$3.83K 2,877 at 1.33
1.7%
Not planned
17 Nov 2025
Higa Tomohiro SVP, Finance
Sold at will
$1.82K 1,367 at 1.33
1.4%
Not planned
18 Aug 2025
Ali Faraz Chief Executive Officer
Sold at will 3×
$18.21K 14,533 at 1.25
4.6%
Not planned
18 Aug 2025
Tingley Whittemore Chief Medical Officer
Sold at will 3×
$6.33K 5,053 at 1.25
2.8%
Not planned
18 Aug 2025
Higa Tomohiro SVP, Finance
Sold at will 3×
$3.71K 2,962 at 1.25
3.0%
Not planned
16 May 2025
Ali Faraz Chief Executive Officer
Sold at will
$1.41K 3,189 at 0.44
1.0%
Not planned
16 May 2025
Tingley Whittemore Chief Medical Officer
Sold at will
$1.30K 2,937 at 0.44
1.7%
Not planned
16 May 2025
Higa Tomohiro SVP, Finance
Sold at will
$615.35 1,390 at 0.44
1.4%
Not planned
10 Mar 2025
Ali Faraz Chief Executive Officer
Sold at will 2×
$5.24K 9,741 at 0.54
2.9%
Not planned
10 Mar 2025
Tingley Whittemore Chief Medical Officer
Sold at will 3×
$3.98K 7,398 at 0.54
4.1%
Not planned
10 Mar 2025
Higa Tomohiro SVP, Finance
Sold at will 3×
$1.34K 2,482 at 0.54
2.4%
Not planned
5 Mar 2025
GOEDDEL DAVID V Director · indirect
Bought
$25.00M 35,714,284 at 0.70
263%
Largest buy in 3 yrs
5 Mar 2025
COLUMN GROUP III GP, LP 10% owner · indirect
Bought
$25.00M 35,714,284 at 0.70
263%
Largest buy in 3 yrs
18 Nov 2024
Saito Chihiro SVP, Accounting and Fin. Ops.
Sold at will
$4.79K 2,258 at 2.12
3.6%
Not planned
16 Aug 2024
Ali Faraz Chief Executive Officer
Sold at will 2×
$28.22K 9,748 at 2.89
4.9%
Not planned
16 Aug 2024
Tingley Whittemore Chief Medical Officer
Sold at will 2×
$21.50K 7,428 at 2.89
6.5%
Not planned
16 Aug 2024
Saito Chihiro SVP, Accounting and Fin. Ops.
Sold at will 3×
$6.84K 2,363 at 2.89
3.6%
Not planned
16 Feb 2024
Tingley Whittemore Chief Medical Officer
Sold at will
$38.09K 6,500 at 5.86
8.1%
Not planned
16 Feb 2024
Ali Faraz Chief Executive Officer
Sold at will
$37.26K 6,358 at 5.86
5.3%
Not planned
16 Feb 2024
PATTERSON LEONE D Chief Fin. and Bus. Officer
Sold at will
$30.48K 5,201 at 5.86
7.9%
Not planned
16 Feb 2024
Hoey Timothy Chief Scientific Officer
Sold at will
$27.43K 4,681 at 5.86
1.9%
Not planned
12 Feb 2024
GOEDDEL DAVID V Director · indirect
Bought
$10.00M 2,222,222 at 4.50
19.5%
12 Feb 2024
COLUMN GROUP III GP, LP 10% owner · indirect
Bought
$10.00M 2,222,222 at 4.50
19.5%
16 Aug 2023
Ali Faraz Chief Executive Officer
Sold at will
$21.20K 5,563 at 3.81
4.5%
Not planned
16 Aug 2023
Tingley Whittemore Chief Medical Officer
Sold at will
$21.20K 5,563 at 3.81
6.8%
Not planned
16 Aug 2023
PATTERSON LEONE D Chief Fin. and Bus. Officer
Sold at will
$16.96K 4,452 at 3.81
6.5%
Not planned
16 Aug 2023
Hoey Timothy Chief Scientific Officer
Sold at will
$15.27K 4,007 at 3.81
1.5%
Not planned
Showing 1–42 of 42.